Table 1 Baseline characteristics of the participants.
Ezetimibe n = 24 | Simvastatin n = 25 | p-value | |
|---|---|---|---|
Women (%) | 79 | 76 | |
Caucasians (%) | 41 | 47 | |
Smoking (%) | 4 | 12 | |
Hypertension (%) | 92 | 80 | |
Age (years) | 53.4 ± 9.3 | 53.1 ± 8.1 | 0.893 |
Body mass index (kg/m2) | 33.1 ± 4.5 | 31.9 ± 3.4 | 0.333 |
Systolic blood pressure (mmHg) | 129.3 ± 16.2 | 124.0 ± 20.4 | 0.325 |
Diastolic blood pressure (mmHg) | 83.3 ± 8.7 | 81.6 ± 11.5 | 0.575 |
Total cholesterol (mg/dL) | 237.4 ± 43.2 | 214.4 ± 39.7 | 0.058 |
LDL-cholesterol (mg/dL) | 145.9 ± 39.9 | 129.4 ± 36.8 | 0.139 |
HDL-cholesterol (mg/dL) | 56.1 ± 13.7 | 53.1 ± 11.5 | 0.408 |
Triglycerides (mg/dL) | 176.8 ± 85.4 | 160.0 ± 65.5 | 0.443 |
Fasting plasma glucose (mg/dL) | 104.3 ± 6.7 | 110.0 ± 11.7 | 0.041 |